Arrowhead Interest Income from 2010 to 2026

ARWR Stock

USD 73.00 3.67 5.29%

Arrowhead Pharmaceuticals Interest Income yearly trend continues to be relatively stable with very little volatility. Interest Income is likely to grow to about 45 M this year. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2010-12-31

Previous Quarter

42.9 M

Current Value

45 M

Quarterly Volatility

15.2 M

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Arrowhead Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arrowhead Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 22.5 M, Interest Expense of 97.6 M or Selling General Administrative of 106 M, as well as many indicators such as Price To Sales Ratio of 4.76, Dividend Yield of 0.0 or PTB Ratio of 9.35. Arrowhead financial statements analysis is a perfect complement when working with Arrowhead Pharmaceuticals Valuation or Volatility modules.

Build AI portfolio with Arrowhead Stock

Check out the analysis of Arrowhead Pharmaceuticals Correlation against competitors.

To learn how to invest in Arrowhead Stock, please use our How to Invest in Arrowhead Pharmaceuticals guide.

Evaluating Arrowhead Pharmaceuticals's Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Arrowhead Pharmaceuticals's fundamental strength.

Latest Arrowhead Pharmaceuticals' Interest Income Growth Pattern

Below is the plot of the Interest Income of Arrowhead Pharmaceuticals over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Arrowhead Pharmaceuticals' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arrowhead Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Arrowhead Interest Income Regression Statistics

	Arithmetic Mean	12,250,654
	Geometric Mean	5,170,396
	Coefficient Of Variation	123.68
	Mean Deviation	11,995,712
	Median	5,033,000
	Standard Deviation	15,151,244
	Sample Variance	229.6T
	Range	45M
	R-Value	0.80
	Mean Square Error	87.9T
	R-Squared	0.64
	Significance	0.0001
	Slope	2,402,517
	Total Sum of Squares	3673T

Arrowhead Interest Income History

	2026	45 M
	2025	42.9 M
	2024	37.3 M
	2023	22.7 M
	2022	15.3 M
	2021	5 M

Other Fundumenentals of Arrowhead Pharmaceuticals

Net Interest Income

Arrowhead Pharmaceuticals Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Good Will	Short Term Investments	Intangible Assets	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.86	0.83	-0.94	0.68	0.71	0.97	1.0	0.88	0.81	0.03	0.6	0.93	0.15	0.99	-0.18	0.55	0.37	0.91	0.21	-0.15	0.94	0.84	0.95	0.97	0.05
Total Stockholder Equity	0.86		0.45	-0.72	0.55	0.73	0.71	0.85	0.73	0.81	0.33	0.71	0.67	0.22	0.78	-0.01	0.79	0.4	0.89	0.26	-0.25	0.79	0.88	0.83	0.8	0.21
Net Debt	0.83	0.45		-0.89	0.61	0.39	0.93	0.83	0.74	0.56	-0.39	0.3	0.93	0.03	0.9	-0.31	0.17	0.24	0.68	0.09	-0.01	0.82	0.53	0.79	0.84	-0.11
Retained Earnings	-0.94	-0.72	-0.89		-0.69	-0.53	-0.95	-0.92	-0.76	-0.81	0.04	-0.59	-0.94	-0.29	-0.94	0.09	-0.5	-0.47	-0.9	-0.32	0.25	-0.92	-0.77	-0.86	-0.89	-0.06
Accounts Payable	0.68	0.55	0.61	-0.69		0.36	0.68	0.66	0.61	0.61	-0.12	0.49	0.81	0.26	0.65	0.0	0.33	0.38	0.71	0.37	-0.16	0.8	0.62	0.61	0.52	-0.18
Net Receivables	0.71	0.73	0.39	-0.53	0.36		0.64	0.7	0.7	0.55	0.35	0.35	0.5	0.03	0.65	-0.15	0.41	0.29	0.58	0.09	-0.09	0.68	0.57	0.73	0.69	-0.06
Total Liab	0.97	0.71	0.93	-0.95	0.68	0.64		0.97	0.87	0.74	-0.1	0.5	0.96	0.1	0.99	-0.24	0.4	0.33	0.84	0.18	-0.1	0.93	0.74	0.92	0.95	-0.03
Total Current Assets	1.0	0.85	0.83	-0.92	0.66	0.7	0.97		0.91	0.81	0.0	0.55	0.92	0.14	0.99	-0.18	0.51	0.35	0.89	0.2	-0.15	0.92	0.81	0.96	0.98	0.03
Short Term Debt	0.88	0.73	0.74	-0.76	0.61	0.7	0.87	0.91		0.67	-0.15	0.27	0.82	0.04	0.89	-0.22	0.24	0.24	0.68	0.11	-0.02	0.76	0.61	0.87	0.9	-0.11
Common Stock	0.81	0.81	0.56	-0.81	0.61	0.55	0.74	0.81	0.67		0.16	0.59	0.72	0.49	0.77	0.24	0.6	0.58	0.88	0.43	-0.64	0.76	0.75	0.76	0.75	0.08
Current Deferred Revenue	0.03	0.33	-0.39	0.04	-0.12	0.35	-0.1	0.0	-0.15	0.16		0.58	-0.19	0.17	-0.1	0.2	0.57	0.25	0.23	0.16	-0.15	0.04	0.43	-0.01	-0.04	0.42
Long Term Debt	0.6	0.71	0.3	-0.59	0.49	0.35	0.5	0.55	0.27	0.59	0.58		0.51	0.23	0.5	0.02	0.87	0.46	0.78	0.26	-0.24	0.65	0.93	0.55	0.48	0.3
Property Plant Equipment	0.93	0.67	0.93	-0.94	0.81	0.5	0.96	0.92	0.82	0.72	-0.19	0.51		0.11	0.95	-0.24	0.38	0.34	0.85	0.19	-0.11	0.93	0.73	0.85	0.86	-0.02
Good Will	0.15	0.22	0.03	-0.29	0.26	0.03	0.1	0.14	0.04	0.49	0.17	0.23	0.11		0.11	0.89	0.18	0.52	0.32	0.64	-0.46	0.18	0.21	0.11	0.09	0.06
Short Term Investments	0.99	0.78	0.9	-0.94	0.65	0.65	0.99	0.99	0.89	0.77	-0.1	0.5	0.95	0.11		-0.23	0.45	0.34	0.87	0.17	-0.1	0.92	0.76	0.94	0.98	0.03
Intangible Assets	-0.18	-0.01	-0.31	0.09	0.0	-0.15	-0.24	-0.18	-0.22	0.24	0.2	0.02	-0.24	0.89	-0.23		-0.03	0.34	0.01	0.53	-0.4	-0.16	-0.06	-0.18	-0.21	0.01
Net Tangible Assets	0.55	0.79	0.17	-0.5	0.33	0.41	0.4	0.51	0.24	0.6	0.57	0.87	0.38	0.18	0.45	-0.03		0.34	0.75	0.22	-0.33	0.57	0.82	0.51	0.46	0.38
Long Term Debt Total	0.37	0.4	0.24	-0.47	0.38	0.29	0.33	0.35	0.24	0.58	0.25	0.46	0.34	0.52	0.34	0.34	0.34		0.5	0.76	-0.43	0.4	0.47	0.35	0.33	0.12
Capital Surpluse	0.91	0.89	0.68	-0.9	0.71	0.58	0.84	0.89	0.68	0.88	0.23	0.78	0.85	0.32	0.87	0.01	0.75	0.5		0.36	-0.31	0.91	0.91	0.82	0.82	0.25
Deferred Long Term Liab	0.21	0.26	0.09	-0.32	0.37	0.09	0.18	0.2	0.11	0.43	0.16	0.26	0.19	0.64	0.17	0.53	0.22	0.76	0.36		-0.29	0.23	0.26	0.18	0.16	0.07
Accumulated Depreciation	-0.15	-0.25	-0.01	0.25	-0.16	-0.09	-0.1	-0.15	-0.02	-0.64	-0.15	-0.24	-0.11	-0.46	-0.1	-0.4	-0.33	-0.43	-0.31	-0.29		-0.15	-0.21	-0.1	-0.09	-0.08
Long Term Investments	0.94	0.79	0.82	-0.92	0.8	0.68	0.93	0.92	0.76	0.76	0.04	0.65	0.93	0.18	0.92	-0.16	0.57	0.4	0.91	0.23	-0.15		0.83	0.9	0.85	-0.07
Short Long Term Debt	0.84	0.88	0.53	-0.77	0.62	0.57	0.74	0.81	0.61	0.75	0.43	0.93	0.73	0.21	0.76	-0.06	0.82	0.47	0.91	0.26	-0.21	0.83		0.79	0.75	0.22
Net Invested Capital	0.95	0.83	0.79	-0.86	0.61	0.73	0.92	0.96	0.87	0.76	-0.01	0.55	0.85	0.11	0.94	-0.18	0.51	0.35	0.82	0.18	-0.1	0.9	0.79		0.96	-0.18
Net Working Capital	0.97	0.8	0.84	-0.89	0.52	0.69	0.95	0.98	0.9	0.75	-0.04	0.48	0.86	0.09	0.98	-0.21	0.46	0.33	0.82	0.16	-0.09	0.85	0.75	0.96		0.03
Capital Stock	0.05	0.21	-0.11	-0.06	-0.18	-0.06	-0.03	0.03	-0.11	0.08	0.42	0.3	-0.02	0.06	0.03	0.01	0.38	0.12	0.25	0.07	-0.08	-0.07	0.22	-0.18	0.03

Click cells to compare fundamentals

About Arrowhead Pharmaceuticals Financial Statements

Arrowhead Pharmaceuticals shareholders use historical fundamental indicators, such as Interest Income, to determine how well the company is positioned to perform in the future. Although Arrowhead Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Arrowhead Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arrowhead Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	42.9 M	45 M
Net Interest Income	-46.9 M	-44.5 M

Pair Trading with Arrowhead Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with Arrowhead Stock

0.83	VRTX	Vertex Pharmaceuticals Earnings Call Tomorrow	Pair Corr
0.75	VYNE	Vyne Therapeutics	Pair Corr

Moving against Arrowhead Stock

0.87	ENSC	Ensysce Biosciences	Pair Corr
0.86	HURA	TuHURA Biosciences	Pair Corr
0.85	CUE	Cue Biopharma	Pair Corr
0.82	XGN	Exagen Inc	Pair Corr
0.73	EDIT	Editas Medicine	Pair Corr

The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.

The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Arrowhead Stock Analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Arrowhead Interest Income from 2010 to 2026

Latest Arrowhead Pharmaceuticals' Interest Income Growth Pattern

Arrowhead Interest Income Regression Statistics

Arrowhead Interest Income History

Other Fundumenentals of Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Interest Income component correlations

About Arrowhead Pharmaceuticals Financial Statements

Pair Trading with Arrowhead Pharmaceuticals

Moving together with Arrowhead Stock

Moving against Arrowhead Stock

Additional Tools for Arrowhead Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY